D05.00 Lobular carcinoma in situ of unspecified breast

Name of the Condition

• Lobular carcinoma in situ of unspecified breast
• Often referred to as "LCIS" or "lobular neoplasia."

Summary

Lobular carcinoma in situ (LCIS) is a non-invasive condition where abnormal cells are found in the lobules (milk-producing glands) of the breast. It is not considered true cancer but indicates an increased risk of developing invasive breast cancer in either breast. LCIS is typically detected incidentally during a biopsy performed for another reason.

Causes

The exact cause of LCIS is not fully understood, but it involves genetic changes in the cells of the breast lobules. Hormonal factors and genetic predispositions may contribute to its development.

Risk Factors

• Female gender, particularly premenopausal or perimenopausal women.
• Family history of breast cancer.
• Genetic mutations, such as in the BRCA1 or BRCA2 genes.
• Prior history of benign breast conditions, like atypical lobular hyperplasia.

Symptoms

LCIS usually does not cause symptoms and is often found during a biopsy for an unrelated breast issue. Rarely, it may be associated with a lump or other breast changes, but these are uncommon.

Diagnosis

LCIS is diagnosed through a breast biopsy, typically performed after an abnormal finding on a mammogram, ultrasound, or MRI. A pathologist examines the tissue to confirm the presence of abnormal lobular cells.

Treatment Options

• Active Surveillance: Regular monitoring with clinical breast exams and imaging, as LCIS is not cancer but indicates risk.
• Risk-Reducing Medications: Tamoxifen or raloxifene may be considered to lower the risk of future invasive cancer.
• Prophylactic Surgery: Bilateral mastectomy is an option for very high-risk individuals, though it is rarely necessary.

Prognosis and Follow-Up

LCIS itself does not spread or become life-threatening, but it increases the risk of developing invasive breast cancer. Follow-up typically includes annual mammograms and clinical breast exams. The risk persists long-term, so ongoing monitoring is important.

Complications

The primary complication is the elevated risk of developing invasive breast cancer in either breast. LCIS does not typically cause physical symptoms or metastasis.

Lifestyle & Prevention

• Maintain a healthy weight and exercise regularly.
• Limit alcohol consumption.
• Discuss risk-reducing strategies with a healthcare provider, especially if there is a family history of breast cancer.

When to Seek Professional Help

Seek medical attention if you notice new breast lumps, skin changes, or discharge. Regular screenings are essential for those with LCIS, even if no symptoms are present.

Tips for Medical Coders

Use D05.00 for lobular carcinoma in situ of unspecified breast. Documentation should specify the breast (unspecified) and confirm the diagnosis via biopsy. Ensure the code aligns with the clinical scenario and avoids confusion with other in situ breast conditions.